AstraZeneca, Peregrine Pharmaceuticals to Collaborate on Immuno-Oncology Combination Clinical Trial

By: via Benzinga
AstraZeneca (NYSE: AZN) and Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today announced that they have entered into a cancer ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.